LeClair Wealth Partners’s iShares US Medical Devices ETF IHI Stock Holding History

LeClair Wealth Partners’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$214K	Buy	+4,019	New	+$236K	0.07%	102

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LeClair Wealth Partners's IHI Position: Q1 2026 in Review

LeClair Wealth Partners opened a new position in iShares US Medical Devices ETF (IHI) in Q1 2026: 4,019 shares worth $214K. The stake represents 0.07% of the portfolio and ranks #102 among its holdings.

503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

LeClair Wealth Partners held 4,019 shares of iShares US Medical Devices ETF worth $214K as of Q1 2026.
iShares US Medical Devices ETF was a new LeClair Wealth Partners position in Q1 2026.
iShares US Medical Devices ETF made up 0.07% of LeClair Wealth Partners's portfolio in Q1 2026, its #102 holding.
503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on LeClair Wealth Partners's 13F filing for Q1 2026, filed 5 May 2026.